Diginex launches supply chain due diligence solution
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/26/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Diginex Expands Supply Chain End-to-End Product Suite Amid Accelerating Regulatory Pressure
June 4, 2026 8:00 AM EDTIn a human rights and supply chain due diligence market valued at approximately $3.8 billion in 2025, non-compliance carries material, financial and reputational consequences.
Diginexs Risk-to-Remedy is an end-to-end solution supporting supply chain transparency and risk surfacing to enable faster, evidence-based action and more defensible reporting.
Upcoming enhancements to Diginexs supply chain offering will enable businesses to make smarter decisions, take effective action and measure outcomes.
LONDON, June 04, 2026 (GLOBE NEWSWIRE) -- Diginex Limited (Nasdaq: DGNX), a provider of ESG,... More
